Management of Hepatocellular Cancer in the time of SARS‐CoV‐2

Por Sharma, Rohini, Pinato, David J.
Publicado no Liver Int (2020)

Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?

Por Hussain, Nadiya, Naeem, Muntaha, Pinato, David J.
Publicado no Hum Vaccin Immunother (2020)

Back from the brink: EGFR inhibition in gastroesophageal cancer

Por Openshaw, Mark R., Pinato, David J., Valeri, Nicola
Publicado no Clin Cancer Res (2021)

Recent advances in HIV-associated Kaposi sarcoma

Por Dalla Pria, Alessia, Pinato, David J., Bracchi, Margherita, Bower, Mark
Publicado no F1000Res (2019)

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy

Por Motedayen Aval, Leila, Pease, James E., Sharma, Rohini, Pinato, David J.
Publicado no J Clin Med (2020)

Evaluating the impact of COVID‐19 on supportive care needs, psychological distress and quality of life in UK cancer survivors and their support network

Por Hulbert‐Williams, Nicholas J., Leslie, Monica, Hulbert‐Williams, Lee, Smith, Eilidh, Howells, Lesley, Pinato, David J.
Publicado no Eur J Cancer Care (Engl) (2021)

Clinical, Ethical and Financial Implications of Incidental Imaging Findings: Experience from a Phase I Trial in Healthy Elderly Volunteers

Por Pinato, David J., Stavraka, Chara, Tanner, Mark, Esson, Audrey, Jacobson, Eric W., Wilkins, Martin R., Libri, Vincenzo
Publicado em 2012

Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study

Por Mletzko, Salvinia, Pinato, David J., Robey, Rebecca C., Dalla Pria, Alessia, Benson, Peter, Imami, Nesrina, Bower, Mark
Publicado no Oncoimmunology (2017)

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior

Por Pinato, David J., Black, James R., Trousil, Sebastian, Dina, Roberto E., Trivedi, Pritesh, Mauri, Francesco A., Sharma, Rohini
Publicado no Oncoimmunology (2017)

Blood Epstein–Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma

Por Ul-Haq, Ikram, Dalla Pria, Alessia, Suardi, Elisa, Pinato, David J., Froeling, Fieke, Forni, John, Randell, Paul, Bower, Mark
Publicado no Med Oncol (2018)

Antibiotic therapy and outcome from immune-checkpoint inhibitors

Por Pinato, David J., Gramenitskaya, Daria, Altmann, Daniel M., Boyton, Rosemary J., Mullish, Benjamin H., Marchesi, Julian R., Bower, Mark
Publicado no J Immunother Cancer (2019)

Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms

Por Fessas, Petros, Possamai, Lucia A., Clark, James, Daniels, Ella, Gudd, Cathrin, Mullish, Benjamin H., Alexander, James L., Pinato, David J.
Publicado no Immunology (2019)

Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapy

Por Pinato, David J., Shiner, Robert J., White, Solomon D. T., Black, James R. M., Trivedi, Pritesh, Stebbing, Justin, Sharma, Rohini, Mauri, Francesco A.
Publicado no Oncoimmunology (2016)

Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma

Por Pinato, David J., Brown, Matthew W., Trousil, Sebastian, Aboagye, Eric O., Beaumont, Jamie, Zhang, Hua, Coley, Helen M., Mauri, Francesco A., Sharma, Rohini
Publicado no Br J Cancer (2019)

Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis

Por Ramaswami, Ramya, Pinato, David J., Kubota, Keiichi, Ishizuka, Mitsuru, Arizumi, Tadaaki, Kudo, Masatoshi, Jang, Jeong Won, Kim, Young Woon, Pirisi, Mario, Allara, Elias, Sharma, Rohini
Publicado no Med Oncol (2016)

Immune-based therapies for hepatocellular carcinoma

Por Pinato, David J., Guerra, Nadia, Fessas, Petros, Murphy, Ravindhi, Mineo, Takashi, Mauri, Francesco A., Mukherjee, Sujit K., Thursz, Mark, Wong, Ching Ngar, Sharma, Rohini, Rimassa, Lorenza
Publicado no Oncogene (2020)

Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma

Por Pinato, David J., Pai, Madhava, Reccia, Isabella, Patel, Markand, Giakoustidis, Alexandros, Karamanakos, Georgios, Rushd, Azelea, Jamshaid, Shiraz, Oldani, Alberto, Grossi, Glenda, Pirisi, Mario, Tait, Paul, Sharma, Rohini
Publicado no BMC Cancer (2018)

An Inflammation Based Score Can Optimize the Selection of Patients with Advanced Cancer Considered for Early Phase Clinical Trials

Por Pinato, David J., Stavraka, Chara, Flynn, Michael J., Forster, Martin D., O'Cathail, Séan M., Seckl, Michael J., Kristeleit, Rebecca S., Olmos, David, Turnbull, Samantha J., Blagden, Sarah P.
Publicado em 2014

Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative...

Por Pinato, David J., Arizumi, Tadaaki, Jang, Jeong Won, Allara, Elias, Suppiah, Puvan I., Smirne, Carlo, Tait, Paul, Pai, Madhava, Grossi, Glenda, Kim, Young Woon, Pirisi, Mario, Kudo, Masatoshi, Sharma, Rohini
Publicado no Oncotarget (2016)

Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib

Por Howell, Jessica A., Pinato, David J., Ramaswami, Ramya, Arizumi, Tadaaki, Ferrari, Carlotta, Gibbin, Antonello, Burlone, Michela E., Guaschino, Giulia, Toniutto, Pierluigi, Black, James, Sellers, Laura, Kudo, Masatoshi, Pirisi, Mario, Sharma, Rohini
Publicado no Oncotarget (2017)